Cubist Systematic Strategies’s Arcus Biosciences RCUS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.84M | Sell |
226,337
-17,971
| -7% | -$146K | 0.01% | 745 |
|
2025
Q1 | $1.92M | Buy |
244,308
+19,141
| +9% | +$150K | 0.01% | 701 |
|
2024
Q4 | $3.35M | Buy |
225,167
+154,874
| +220% | +$2.31M | 0.02% | 458 |
|
2024
Q3 | $1.07M | Sell |
70,293
-14,170
| -17% | -$217K | 0.01% | 793 |
|
2024
Q2 | $1.29M | Buy |
+84,463
| New | +$1.29M | 0.01% | 704 |
|
2023
Q4 | – | Sell |
-80,031
| Closed | -$1.44M | – | 2562 |
|
2023
Q3 | $1.44M | Buy |
80,031
+79,842
| +42,244% | +$1.43M | 0.01% | 905 |
|
2023
Q2 | $3.84K | Sell |
189
-67,841
| -100% | -$1.38M | ﹤0.01% | 2132 |
|
2023
Q1 | $1.24M | Sell |
68,030
-40,874
| -38% | -$746K | 0.01% | 1357 |
|
2022
Q4 | $2.25M | Buy |
108,904
+36,430
| +50% | +$753K | 0.01% | 1234 |
|
2022
Q3 | $1.9M | Sell |
72,474
-43,708
| -38% | -$1.14M | 0.01% | 1626 |
|
2022
Q2 | $2.94M | Buy |
116,182
+67,294
| +138% | +$1.71M | 0.02% | 1251 |
|
2022
Q1 | $1.54M | Sell |
48,888
-17,464
| -26% | -$551K | 0.01% | 1699 |
|
2021
Q4 | $2.69M | Buy |
66,352
+50,261
| +312% | +$2.03M | 0.03% | 1119 |
|
2021
Q3 | $561K | Sell |
16,091
-13,266
| -45% | -$463K | 0.01% | 1952 |
|
2021
Q2 | $806K | Buy |
29,357
+11,732
| +67% | +$322K | 0.01% | 1717 |
|
2021
Q1 | $495K | Sell |
17,625
-4,625
| -21% | -$130K | 0.01% | 1968 |
|
2020
Q4 | $578K | Sell |
22,250
-14,245
| -39% | -$370K | 0.01% | 1692 |
|
2020
Q3 | $626K | Sell |
36,495
-32,381
| -47% | -$555K | 0.01% | 1607 |
|
2020
Q2 | $1.7M | Buy |
+68,876
| New | +$1.7M | 0.03% | 893 |
|
2019
Q3 | – | Sell |
-20,494
| Closed | -$163K | – | 2419 |
|
2019
Q2 | $163K | Buy |
+20,494
| New | +$163K | ﹤0.01% | 2130 |
|
2018
Q3 | – | Sell |
-10,009
| Closed | -$123K | – | 2027 |
|
2018
Q2 | $123K | Buy |
10,009
+1,113
| +13% | +$13.7K | 0.01% | 1474 |
|
2018
Q1 | $137K | Buy |
+8,896
| New | +$137K | 0.01% | 1528 |
|